Baudic M, Murata H, Bosada FM, Melo US, Aizawa T, Lindenbaum P, van der Maarel LE, Guedon A, Baron E, Fremy E, Foucal A, Ishikawa T, Ushinohama H, Jurgens SJ, Choi SH, Kyndt F, Le Scouarnec S, Wakker V, Thollet A, Rajalu A, Takaki T, Ohno S, Shimizu W, Horie M, Kimura T, Ellinor PT, Petit F, Dulac Y, Bru P, Boland A, Deleuze JF, Redon R, Le Marec H, Le Tourneau T, Gourraud JB, Yoshida Y, Makita N, Vieyres C, Makiyama T, Mundlos S, Christoffels VM, Probst V, Schott JJ, Barc J. TAD boundary deletion causes PITX2-related cardiac electrical and structural defects. Nat Commun. 2024 Apr 20.
Kayawake H, Tanaka S, Yamada Y, Baba S, Kinoshita H, Yamazaki K, Ikeda T, Minatoya K, Yutaka Y, Hamaji M, Ohsumi A, Nakajima D, Date H. Comparison of living-donor lobar lung transplantation and cadaveric lung transplantation for pulmonary hypertension. Eur J Cardiothorac Surg. 2023 Apr 3. doi: 10.1093/ejcts/ezad024.
Horie T, OnoK. VERVE-101: A Promising CRISPR-based Gene Editing Therapy that Reduces LDL-C and PCSK9 Levels in HeFH Patients. Eur Heart J Cardiovasc Pharmacother. 2023 in press.
Shiomi H, Hasegawa K, Ono K. What is optimal DAPT duration after PCI?. Eur Heart J Cardiovasc Pharmacother. 2023 Nov 9 Epub ahead of print. doi: 10.1093/ehjcvp/pvad084. PMID: 37950560.
Yamashita Y, Nakayama A, Oi M, Sugioka S, Nakano Y, Naka M, Yasuda S, Onishi M, Yamamoto E, Ono K. Sex Differences in the Japanese Circulation Society Guideline Writing Committee Authorship Between 2008 and 2022. Circ Cardiovasc Qual Outcomes. 2023 Jun Epub 2023 Jun 20. doi: 10.1161/CIRCOUTCOMES.123.010029. PMID: 37339193.
Yamashita Y, Yachi S, Takeyama M, Nishimoto Y, Tsujino I, Nakamura J, Yamamoto N, Nakata H, Ikeda S, Umetsu M, Aikawa S, Hayashi H, Satokawa H, Okuno Y, Iwata E, Ogihara Y, Ikeda N, Kondo A, Iwai T, Yamada N, Ogawa T, Kobayashi T, Mo M. Significant Impact of Age on Mortality and Non-significant Impact of Age on Thrombosis and Major Bleeding in Patients with COVID-19: From the CLOT-COVID Study. J Atheroscler Thromb. 2023 Jun 1.
Yamashita Y, Kobayashi T, Mo M. Thrombosis and Anticoagulation Strategies in Patients with COVID-19 Including Japanese Perspective. J Atheroscler Thromb. 2023 Apr 1.
Yamashita Y. Utility of Rivaroxaban for Real-World Patients With Venous Thromboembolism. Circ J. 2023 Aug 25.
Yamashita Y, Morimoto T, Muraoka N, Oyakawa T, Umetsu M, Akamatsu D, Nishimoto Y, Sato Y, Takada T, Jujo K, Minami Y, Ogihara Y, Dohi K, Fujita M, Nishikawa T, Ikeda N, Hashimoto G, Otsui K, Mori K, Sueta D, Tsubata Y, Shoji M, Shikama A, Hosoi Y, Tanabe Y, Chatani R, Tsukahara K, Nakanishi N, Kim K, Ikeda S, Mo M, Yoshikawa Y, Kimura T; ONCO DVT Study Investigators. Edoxaban for 12 Months Versus 3 Months in Patients With Cancer With Isolated Distal Deep Vein Thrombosis (ONCO DVT Study): An Open-Label, Multicenter, Randomized Clinical Trial. Circulation. 2023 Nov 21.
Kato ET, Morrow DA, Guo J, Berg DD, Blazing MA, Bohula EA, Bonaca MP, Cannon CP, de Lemos JA, Giugliano RP, Jarolim P, Kempf T, Kristin Newby L, O'Donoghue ML, Pfeffer MA, Rifai N, Wiviott SD, Wollert KC, Braunwald E, Sabatine MS. Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis. European Heart Journal. 2023. doi: 10.1093/eurheartj/ehac577.
Kato ET, Sato J. Addressing health and demographic challenges in Japan’s ageing society. The Lancet Diabetes & Endocrinology. 2023. doi: 10.1016/S2213-8587(23)00197-3.
Kato ET, Ono K, Lewis BS. SGLT2 inhibitors in acute myocardial infarction: what can we learn from the DAPA-MI trial? More news from AHA. Eur Heart J Cardiovasc Pharmacother. 2023 Dec 7 Epub ahead of print. doi: 10.1093/ehjcvp/pvad099. PMID: 38061802.
Kato ET, Lewis BS, Ono K. GLP-1 receptor agonists: new game changing drugs in patients with heart failure with preserved ejection fraction and obesity. Eur Heart J Cardiovasc Pharmacother. 2023 Dec 14. doi: 10.1093/ehjcvp/pvad072. PMID: 37777847.
Kasamoto, M, Funakoshi, S, Hatani T, Okubo C, Nishi Y, Tsujisaka Y, Nishikawa M, Narita M, Ohta A, Kimura T, Yoshida Y. Am80, a retinoic acid receptor agonist, activates the cardiomyocyte cell cycle and enhances engraftment in the heart. Stem Cell Reports. 2023 Aug 8.
Aizawa T, Wada Y, Hasegawa K, Huang H, Imamura T, Gao J, Kashiwa A, Kohjitani H, Fukuyama M, Kato K, Kato ET, Hisamatsu T, Ohno S, Makiyama T, Kimura T, Horie M. Non-missense variants of KCNH2 show better outcomes in type 2 long QT syndrome. Europace. 2023 Apr 15.
Nishiwaki S, Shizuta S, Tanaka M, Kohjitani H, Ono K. Successful cardiac synchronization therapy device upgrade using an active fixation quadripolar pacing lead in a patients with persistent left superior vena cava and absent right superior vena cava. J Arrhythm. 2023 Jul 31. doi: 10.1002/joa3.12905. PMID: 37799803.
Yoneda F, Yamashita Y, Watanabe S, Ono K. A case of a systemic cancer-associated thrombosis successfully treated with multi-disciplinary treatment including anticoagulation therapy and anticancer drug therapy. Eur Heart J Case Rep. 2023 Oct 18. doi: 10.1093/ehjcr/ytad517. PMID: 37942354.
Miyagawa S, Horie T, Nishino T, Koyama S, Watanabe T, Baba O, Yamasaki T, Sowa N, Otani C, Matsushita K, Kojima H, Kimura M, Nakashima Y, Obika S, Kasahara Y, Kotera J, Oka K, Fujita R, Sasaki T, Takemiya A, Hasegawa K, Kimura T, Ono K*. Inhibition of microRNA-33b in humanized mice ameliorates nonalcoholic steatohepatitis. Life Sci Alliance. 2023 Jun 1. doi: 10.26508/lsa.202301902. PMID: 37263777.
Shiba M, Kato T, Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Seko Y, Yamamoto E, Yoshikawa Y, Kitai T, Yamashita Y, Iguchi M, Nagao K, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T. Heterogeneity in characteristics and outcomes of patients who met the indications for vericiguat approved by the Japanese agency: from the KCHF registry. J Cardiac Fail. 2023 April 12. doi: 10.1016/j.cardfail.2023.03.023.
Yamamoto K, Shiomi H, Morimoto T, Miyazawa A, Watanabe H, Nakamura S, Suwa S, Domei T, Ono K, Sakamoto H, Shigetoshi M, Taniguchi R, Okayama H, Toyota T, Yokomatsu T, Muto M, Kawaguchi R, Kishi K, Hadase M, Fujita T, Nishida Y, Nishino M, Otake H, Natsuaki M, Watanabe H, Suematsu N, Tanabe K, Abe M, Hibi K, Kadota K, Ando K, Kimura T. OPTIVUS-Complex PCI Investigators. Single-Session Versus Staged Multivessel Optimal IVUS-Guided PCI in Patients With CCS or NSTEACS. JACC Asia. 2023 Jun 13. doi: 10.1016/j.jacasi.2023.03.013. PMID: 37614540.
Yamamoto K, Shiomi H, Morimoto T, Miyazawa A, Watanabe H, Nakamura S, Suwa S, Domei T, Ono K, Sakamoto H, Shigetoshi M, Taniguchi R, Okayama H, Yokomatsu T, Muto M, Kawaguchi R, Kishi K, Hadase M, Fujita T, Nishida Y, Nishino M, Otake H, Natsuaki M, Watanabe H, Suematsu N, Tanabe K, Abe M, Hibi K, Kadota K, Ando K, Kimura T. OPTIVUS-Complex PCI Investigators. Dual Antiplatelet Therapy Duration After Multivessel Optimal Intravascular Ultrasound-Guided Percutaneous Coronary Intervention. Circ J. 2023 Oct 25 Epub 2023 May 16. doi: 10.1253/circj.CJ-23-0141. PMID: 37197941.
Yamamoto K, Shiomi H, Morimoto T, Miyazawa A, Watanabe H, Natsuaki M, Watanabe H, Yamaji K, Ohya M, Nakamura S, Mitomo S, Suwa S, Domei T, Tatsushima S, Ono K, Sakamoto H, Shimamura K, Shigetoshi M, Taniguchi R, Nishimoto Y, Okayama H, Matsuda K, Yokomatsu T, Muto M, Kawaguchi R, Kishi K, Hadase M, Fujita T, Nishida Y, Nishino M, Otake H, Suematsu N, Ajimi T, Tanabe K, Abe M, Hibi K, Kadota K, Ando K, Kimura T. OPTIVUS-Complex PCI Investigators*. Target Lesion Revascularization After Intravascular Ultrasound-Guided Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2023 May Epub 2023 May 16. doi: 10.1161/CIRCINTERVENTIONS.123.012922. PMID: 37192307.
Tsujisaka Y, Yamashita Y, Morimoto T, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Chen PM, Murata K, Tsuyuki Y, Nishimoto Y, Sakamoto J, Togi K, Mabuchi H, Takabayashi K, Kato T, Ono K, Kimura T; COMMAND VTE Registry Investigators. Application of the RIETE score to identify low-risk patients with pulmonary embolism: From the COMMAND VTE Registry. Thromb Res. 2023 Dec Epub 2023 Oct 24. doi: 10.1016/j.thromres.2023.10.015. PMID: 37922657.
Obayashi Y, Kato T, Yaku H, Morimoto T, Seko Y, Inuzuka Y, Tamaki Y, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Su K, Kawato M, Inoko M, Toyofuku T, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Sato Y, Kuwahara K, Ozasa N, Kimura T. Tricuspid Regurgitation in Elderly Patients with Acute Heart Failure: Insights from the KCHF registry. ESC Heart Fail. 2023 Jun.
Obayashi Y, Shiomi H, Morimoto T, Miyake M, Inoko M, Nishikawa R, Kaneda K, Yamamoto K, Takeji Y, Tada T, Nagao K, Uegaito T, Ehara N, Sakai H, Suwa S, Tamura T, Sakamoto H, Inada T, Matsuda M, Sato Y, Furukawa Y, Ando K, Kadota K, Nakagawa Y, Kimura T; CREDO-Kyoto AMI Registry Wave-2 Investigators. The Impact of Mitral Regurgitation on Long-Term Outcomes in Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention. Am J Cardiol. 2023 Jul 28.
Nishikawa R, Kato T, Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Yamamoto E, Ozasa N, Tada T, Sakamoto H, Seko Y, Shiba M, Yoshikawa Y, Yamashita Y, Kitai T, Taniguchi R, Iguchi M, Nagao K, Kawai T, Komasa A, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T. KCHF Study Investigators. The characteristics and outcomes in patients with acute heart failure who used tolvaptan: from KCHF registry. ESC Heart Fail. 2023 Aug 29. doi: 10.1002/ehf2.14494.
Yuzuru Matsumoto, Shinya Ikeda, Takeshi Kimura, Koh Ono & Noboru Ashida. Col1α2‐Cre‐mediated recombination occurs in various cell types due to Cre expressionin epiblasts. Scientific Reports. 2023 Dec 18. doi: 10.1038/s41598-023-50053-z.
Fujiwara Y, Miki K, Deguchi K, Naka Y, Sasaki M, Sakoda A, Narita M, Imaichi S, Sugo T, Funakoshi S, Nishimoto T, Imahashi K, Yoshida Y*. ERRγ agonist under mechanical stretching manifests hypertrophic cardiomyopathy phenotypes of engineered cardiac tissue through maturation. Stem Cell Reports. 2023 Sep 21.
Gohbara M, Hibi K, Morimoto T, Kirigaya H, Yamamoto K, Ono K, Shiomi H, Ohya M, Yamaji K, Watanabe H, Amano T, Morino Y, Takagi K, Honye J, Matsuo H, Abe M, Kadota K, Ando K, Nakao K, Sonoda S, Suwa S, Kawai K, Kozuma K, Nakagawa Y, Ikari Y, Nanasato M, Hanaoka K, Tanabe K, Hata Y, Akasaka T, Kimura T; OPTIVUSComplex PCI investigators. SYNTAX Score and 1-Year Outcomes in the OPTIVUSComplex PCI Study Multivessel Cohort. Am J Cardiol. 2023 Oct 15 Epub 2023 Sep 1. doi: 10.1016/j.amjcard.2023.08.043. PMID: 37660669.
Saeko Imai, Shizuo Kajiyama, Kaoru Kitta, Takashi Miyawaki, Shinya Matsumoto, Neiko Ozasa, Shintaro Kajiyama, Yoshitaka Hashimoto, Michiaki Fukui. Eating Vegetables First Regardless of Eating Speed Has a Significant Reducing Effect on Postprandial Blood Glucose and Insulin in Young Healthy Women: Randomized Controlled Cross-Over Study. Nutrients. 2023. doi: 10.3390/nu15051174.
Kanai M, Minamisawa M, Motoki H, Seko Y, Kimura K, Okano T, Ueki Y, Yoshie K, Kato T, Saigusa T, Ebisawa S, Okada A, Ozasa N, Kato T, Kuwahara K. Prognostic Impact of Hyperpolypharmacy Due to Noncardiovascular Medications in Patients After Acute Decompensated Heart Failure – Insights From the Clue of Risk Stratification in the Elderly Patients With Heart Failure (CURE-HF) Registry. Circ J. 2023 Aug 4. doi: 10.1253/circj.CJ-22-0712.
Seko Y, Kato T, Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Shiba M, Yamamoto E, Yoshikawa Y, Kitai T, Yamashita Y, Iguchi M, Nagao K, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T. Weight loss during follow-up in patients with acute heart failure: From the KCHF registry. PLoS One. 2023 Jun 23. doi: 10.1371/journal.pone.0287637.
Umemura I, Eguchi S, Morita Y, Mitani H, Iekushi K, Kato T. Relationship Between Left Ventricular Ejection Fraction and Treatment Characteristics in Hospitalized Patients With Heart Failure ― A Japanese Database Analysis ―. Circ Rep. 2023 Sep 21.
Utsunomiya Y, Miyake KK, Fukushima S, Kinoshita H, Ikeda Y, Matsumoto M, Hatakeyama K, Kato T, Kawatou M, Minatoya K, Nakamoto Y. 18F-FDG PET/CT in left atrial undifferentiated pleomorphic sarcoma with osteosarcomatous differentiation. J Cardiol Cases. 2023 Sep 27.
Takahashi K, Yamashita Y, Morimoto T, Tada T, Sakamoto H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Chen PM, Murata K, Tsuyuki Y, Nishimoto Y, Sakamoto J, Togi K, Mabuchi H, Takabayashi K, Kato T, Ono K, Kimura T; COMMAND VTE Registry Investigators. Age and long-term outcomes of patients with venous thromboembolism: From the COMMAND VTE Registry. Int J Cardiol. 2023 May 6 Online ahead of print. doi: 10.1016/j.ijcard.2023.04.050. PMID: 37156304.
Takeji Y, Taniguchi T, Morimoto T, Shirai S, Kitai T, Tabata H, Kitano K, Ohno N, Murai R, Osakada K, Murata K, Nakai M, Tsuneyoshi H, Tada T, Amano M, Watanabe S, Shiomi H, Watanabe H, Yoshikawa Y, Nishikawa R, Yamamoto K, Obayashi Y, Toyofuku M, Tatsushima S, Kanamori N, Miyake M, Nakayama H, Nagao K, Izuhara M, Nakatsuma K, Inoko M, Fujita T, Kimura M, Ishii M, Usami S, Sawada K, Nakazeki F, Okabayashi M, Shirotani M, Inuzuka Y, Ando K, Komiya T, Minatoya K CURRENT AS registry-2 Investigators; Kimura T. In-hospital outcomes after SAVR or TAVI in patients with severe aortic stenosis. Cardiovasc Interv Ther. 2023 Jun 22.
Tsuji S, Otani C, Horie T, Watanabe S, Baba O, Sowa N, Ide Y, Kashiwa A, Makiyama T, Imai H, Nakashima Y, Yamasaki T, Xu S, Matsushita K, Suzuki K, Zou F, Kume E, Hasegawa K, Kimura T, Kakizuka A, Ono K. KUS121, a VCP modulator, has an ameliorating effect on acute and chronic heart failure without calcium loading via maintenance of intracellular ATP levels. Biomed Pharmacother. 2023 Dec 12 Epub ahead of print. doi: 10.1016/j.biopha.2023.115850. PMID: 38091636.
Natsuaki M, Watanabe H, Morimoto T, Yamamoto K, Obayashi Y, Nishikawa R, Ando K, Domei T, Suwa S, Ogita M, Isawa T, Takenaka H, Yamamoto T, Ishikawa T, Hisauchi I, Wakabayashi K, Onishi Y, Hibi K, Kawai K, Yoshida R, Suzuki H, Nakazawa G, Kusuyama T, Morishima I, Ono K, Kimura T. An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial. Circulation. 2023 Nov 23 Epub ahead of print. doi: 10.1161/CIRCULATIONAHA.123.066720. PMID: 37994553.
Natsuaki M, Watanabe H, Morimoto T, Kozuma K, Kadota K, Muramatsu T, Nakagawa Y, Akasaka T, Hanaoka KI, Tanabe K, Morino Y, Ishikawa T, Katoh H, Nishikawa H, Tamura T, Ono K, Yamamoto K, Ishihara T, Abe M, Taniguchi R, Ikari Y, Okada K, Kimura T. Biodegradable or durable polymer drug-eluting stents in patients with coronary artery disease: ten-year outcomes of the randomised NEXT Trial. EuroIntervention. 2023 Aug 7. doi: 10.4244/EIJ-D-23-00076. PMID: 37395475.
Natsuaki M, Watanabe H, Morimoto T, Yamamoto K, Obayashi Y, Nishikawa R, Ando K, Domei T, Suwa S, Ogita M, Isawa T, Takenaka H, Yamamoto T, Ishikawa T, Hisauchi I, Wakabayashi K, Onishi Y, Hibi K, Kawai K, Yoshida R, Suzuki H, Nakazawa G, Kusuyama T, Morishima I, Ono K, Kimura T. An Aspirin-Free versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial. Circulation. 2023 In Press.
Yamamoto Y, Okawa M, Suzuki K, Tateya I, Yoshimura M, Fushimi Y, Kato ET, Yoshida K, Miyamoto S. Continuous and Early Progression of Carotid Intima-Media Thickness after Radiotherapy for Head and Neck Cancer: 5-Year Prospective Observational Study.. Cerebrovascular Disease. 2023. doi: 10.1159/000528622.
Watanabe H, Morimoto T, Natsuaki M, Yamamoto K, Obayashi Y, Nishikawa R, Ando K, Ono K, Kadota K, Suwa S, Morishima I, Yoshida R, Hata Y, Akao M, Yagi M, Suematsu N, Morino Y, Yokomatsu T, Takamisawa I, Noda T, Doi M, Okayama H, Nakamura Y, Hibi K, Sakamoto H, Noguchi T, Kimura T; STOPDAPT-2 investigators. Clopidogrel versus Aspirin Monotherapy Beyond 1 Year After PCI: STOPDAPT-2 5-Year Results. J Am Coll Cardiol. 2023 Oct 18 Epub ahead of print. doi: 10.1016/j.jacc.2023.10.013. PMID: 37879491.
Baudic M, Murata H, Bosada FM, Melo US, Aizawa T, Lindenbaum P, van der Maarel LE, Guedon A, Baron E, Fremy E, Foucal A, Ishikawa T, Ushinohama H, Jurgens SJ, Choi SH, Kyndt F, Le Scouarnec S, Wakker V, Thollet A, Rajalu A, Takaki T, Ohno S, Shimizu W, Horie M, Kimura T, Ellinor PT, Petit F, Dulac Y, Bru P, Boland A, Deleuze JF, Redon R, Le Marec H, Le Tourneau T, Gourraud JB, Yoshida Y, Makita N, Vieyres C, Makiyama T*, Mundlos S*, Christoffels VM*, Probst V*, Schott JJ*, Barc J*. TAD boundary deletion causes PITX2-related cardiac electrical and structural defects. Nat Commun. 2024 Apr 20.
Kohjitani, H., Koshimizu, H., Nakamura, K. & Okuno, Y. Recent developments in machine learning modeling methods for hypertension treatment. Hypertens. 2024. doi: 10.1038/s41440-023-01547-w.
Nakanishi-Koakutsu M, Miki K*, Naka Y, Sasaki M, Wakimizu T, Napier SC, Okubo C, Narita M, Nishikawa M, Hata R, Chonabayashi K, Hotta A, Imahashi K, Nishimoto T, Yoshida Y. CD151 expression marks atrial- and ventricular- differentiation from human induced pluripotent stem cells. Commun Biol. 2024 Feb 28.
Kashiwa A, Itoh H, Makiyama T, Wada Y, Ozawa J, Kato K, Fukuyama M, Nakajima T, Ohno S, Horie M. Clinical characterization of type 1 long QT syndrome caused by C-terminus Kv7.1 variants. Heart Rhythm. 2024 Feb 15.
Fukuyama M, Horie M, Kato K, Aoki H, Fujita S, Yoshida Y, Sakazaki H, Toda T, Ueno M, Izumi G, Momoi N, Muneuchi J, Makiyama T, Nakagawa Y, Ohno S. Calmodulinopathy in Japanese Children – Their Cardiac Phenotypes Are Severe and Show Early Onset in Fetal Life and Infancy. Circ J. 2023.
Xu S, Shiomi H, Yamashita Y, Koyama S, Horie T, Baba O, Kimura M, Nakashima Y, Sowa N, Hasegawa K, Suzuki A, Suzuki Y, Kimura T, Ono K. CRISPR-Cas9-guided amplification-free genomic diagnosis for familial hypercholesterolemia using nanopore sequencing. PLoS One. 2024 Mar 20.
Nagao K, Maruichi-Kawakami S, Aida K, Matsuto K, Imamoto K, Yukawa H, Kanazawa T, Kobayashi Y, Takahashi N, Ito H, Hayashi F, Inada T. Association Between the Liver Fibrosis Markers and Scores, and Hemodynamic Congestion Assessed by Peripheral Venous Pressure in Patients With Acute Heart Failure. J Am Heart Assoc. 2023 Nov 7. Epub 2023 Nov 6. doi: 10.1161/JAHA.123.030788. PMID: 37929710.
Maruichi-Kawakami S, Nagao K, Aida K, Matsuto K, Imamoto K, Tamura A, Takazaki T, Nakatsu T, Tanaka M, Nakayama S, Morimoto T, Kimura T, Inada T. Peripheral Venous Pressure Measurements to Evaluate Congestion in Heart Failure. J Card Fail. 2023 Sep. Epub 2022 Jan 15. doi: 10.1016/j.cardfail.2021.11.018. PMID: 35042656.
山下 侑吾. がん治療中に合併する血栓塞栓症. 日本血栓止血学会誌「特集総説」.
尾野 亘. 核酸医薬による循環器・代謝疾患治療. Medical Science Digest. 2023.
Yuta Tsujisaka, Hiroki Ono, Kenji Miki, Hirohide Saito, Yoshinori Yoshida. Isolation of mature human iPSC-derived ventricular cardiomyocytes using synthetic microRNA switch. European Society of Cardiology Congress 2023. Amsterdam. August 28 2023.
Yuta Tsujisaka. Isolation of Mature Human iPSC-Derived Ventricular Cardiomyocytes Using Synthetic MicroRNA Switch. ISSCR annual meeting. Boston, USA. June 14-17 2023.
加藤恵理. 心不全患者における血栓症マネジメント. Meet the Specialists in Amsterdam. Amsterdam, Netherlands. August 26 2023.
Yugo Yamashita, Takeshi Morimoto, Nao Muraoka, Michihisa Umetsu, Yuji Nishimoto, Takuma Takada, Yoshito Ogihara, Masashi Fujita, Nobutaka Ikeda, Kazunori Otsui, Daisuke Sueta, Yukari Tsubata, Masaaki Shoji, Ayumi Shikama, Takeshi Kimura. Edoxaban for 3 months versus 12 months in cancer patients with isolated distal deep vein thrombosis: ONCO DVT Study. HOT LINE 9. European Society of Cardiology Congress 2023. Amsterdam. August 28 2023.
Eri Kato. Daily Highlights by the Asian Pacific Society of Cardiology European Society of Cardiology.. European Society of Cardiology Congress 2023. Amsterdam. August 28 2023.
T. Aizawa, T. Makiyama, H. Murata, T. Takaki, M. Baudic, J. Gao, T. Imamura, S. Ohno, Y. Yoshida, W. Shimizu, N. Makita, J. Barc, J.J. Schott, M. Horie, T. Kimura. Modeling familial sinus node dysfunction with a large intergenic deletion between PITX2 and ANK2 using iPS cell-derived sinoatrial nodal-like cardiomyocytes. European Society of Cardiology Congress 2023. Amsterdam. August 28 2023.
Shunsuke Funakoshi, Masako Sasaki, Shigeru Kondo, Yuki Naka, Kenichi Imahashi, Yoshinori Yoshida. MACHINE LEARNING-BASED SCREENING SYSTEM USING HPSC-DERIVED CARDIOMYOCYTES FOR THE DISCOVERY OF NOVEL THERAPIES TO ATTENUATE DOXORUBICIN-INDUCED CARDIAC DAMAGES. European Society of Cardiology Congress 2023. Amsterdam. August 28 2023.
Fumika Inazuka, Shunsuke Funakoshi, Yuya Fujiwara, Masako Sasaki, Shigeru Kondo, Hidetoshi Sakurai, Yoshinori Yoshida. Establishment of 3D mature cardiac tissue platfor+D100ms for modeling DMD cardiomyopathy. European Society of Cardiology Congress 2023. Amsterdam. August 28 2023.
Shigeru Kondo, Kohei Deguchi, Ayaka Sakoda, Misato Koakutsu, Yuki Naka, Masako Sasaki, Tomoyuki Nishimoto, Kenichi Imahashi, Yoshinori Yoshida. High-throughput Phenotypic Screening for Hypertrophic Cardiomyopathy using Human iPS Cell–Derived Cardiomyocytes. European Society of Cardiology Congress 2023. Amsterdam. August 28 2023.
Kanae Tani, Shunsuke Funakoshi, Antonio Lucena-Cacace, Hiromitsu Fuse, Yoshinori Yoshida. High Throughput Screening identifies new compounds to enhance human iPSC-derived cardiomyocyte maturation. European Society of Cardiology Congress 2023. Amsterdam. August 28 2023.
Tian Yu, Antonio Lucena-Cacace, Yoshinori Yoshida. Generation of mature epicardium derived from human-induced pluripotent stem cells via inhibition of mTOR signaling. European Society of Cardiology Congress 2023. Amsterdam. August 28 2023.
Kanae Tani, Yu Tian, Ian Costa Paixao, Megumi Narita, Antonio Lucena-Cacace, Yoshinori Yoshida. Generation of mature engineered heart tissues by small-molecules enhancing the contraction force of quiescent human iPS-derived cardiomyocytes. CARDIOVASCULAR BIOENGINEERING (CVBE) SYMPOSIUM 2023. Kyoto, Japan. May 29-31 2023.
Takeru Makiyama. Cellular and subcellular mechanisms of cardiac arrhythmia Disrupted CaV1.2 selectivity causes overlapping long QT and Brugada syndrome phenotypes in tips cell model ―iPS cell-based model for the study of inherited arrhythmias― (oral, invited). 16th Asia Pacific Heart Rhythm Society (APHRS) Scientific Session. Hong Kong. August 31-September 3 2023.
Eri Kato. The Cardiovascular Link: Preventing Diabetes for a Healthy Heart (invited). The Great Wall International Congress of Cardiology. Beijing, China. September 8 2023.
Osamu Baba. Chemokine Receptor Targeting PET Imaging of Atherosclerosis. 16th Asian Pacific Society of Atherosclerosis and Vascular Disease Congress 2023 (APSAVD2023). Kuala Lumpur, Malaysia. September 8 2023.
Eri Kato. Cancer Risk in Heart Failure Patients. International Congress of Update in Cardiology and Cardiovascular Surgery. Istanbul, Turkey. November 5-6 2023.
Eri Kato. Heart Failure and Ageing Society: From HFpEF to Onco-cardiology (invited). International Congress of Update in Cardiology and Cardiovascular Surgery. Istanbul, Turkey. November 5-6 2023.
Nagao K, Kato T. Distinct Prognostic Impact of Clinical Congestion Based on Left Ventricular Ejection Fraction in Patients Hospitalized for Decompensated Heart Failure. American Heart Association Scientific Sessions 2023. Philadelphia, USA. November11-13 2023.
Munekazu Tanaka, Hirohiko Kohjitani, Tomoyuki Inoue, Akifumi Morinaga, Fumiya Yoneda, Shushi Nishiwaki, Satoshi Shizuta, Yasushi Okuno, Koh Ono. Development of Deep Neural Network Models for Identification of Pulmonary Vein Potentials From Body Surface Electrocardiograms of Patients With Atrial Fibrillation. American Heart Association Scientific Sessions 2023. Philadelphia, USA. November11-13 2023.
Ryusuke Nishikawa, Shin Watanabe, Munekazu Tanaka, Hiroki Shiomi, Yugo Yamashita, Erika Yamamoto, Kyohei Yamaji, Koh Ono. Impact of Timing of Venoarterial Extracorporeal Membrane Oxygenation Insertion (Before or After Impella) in Patients With Acute Myocardial Infarction With Cardiogenic Shock Using Impella: From J-PVAD Registry. American Heart Association Scientific Sessions 2023. Philadelphia, USA. November11-13 2023.
Yoshinori Yoshida. Efficient Reconstruction of the Failing Heart Using iPS Cells. ADSCC 2023 Bone Marrow Transplant & Cellular Therapy Congress. Abu Dhabi, UAE. November18-19 2023.
Eri Kato. New therapeutic target in cardiovascular field. Diamond International Meeting on Cardiovascular Disease. Copenhagen, Denmark. May 17 2023.
Yoshinori Yoshida. Generation of cardiac cells and tissues from iPS cells for biomedical applications. CARDIOVASCULAR BIOENGINEERING (CVBE) SYMPOSIUM 2023. Kyoto, Japan. May 29-31 2023.
Hirohiko Kohjitani, Munekazu Tanaka, Misaki Naka, Tomoyuki Inoue, Akifumi Morinaga, Fumiya Yoneda, Shushi Nishiwaki, Satoshi Shizuta, Yasushi Okuno. Development of Deep-Neural-Network Based Artificial Intelligence Models for Identification of Pulmonary Vein Potentials from 12-Leads Electrocardiogram of Patients with Atrial Fibrillation. 第69回日本不整脈心電学会学術大会. 札幌. 2023年7月6-9日.
Munekazu Tanaka, Hirohiko Kohjitani, Fumiya Yoneda, Shushi Nishiwaki, Satoshi Shizuta, Yasushi Okuno. The Accuracy Differences in Developing A Deep Neural Network to Identify Pulmonary Vein Potentials Depend On Input Leads of A 12-leads Electrocardiogram. 第69回日本不整脈心電学会学術大会. 札幌. 2023年7月6-9日.
Leo Hata, Takao Kato, Takeshi Makiyama, Yoshinori Yoshida. Cardiac Fibrosis Score Based on Myocardial Biopsy Transcriptome in Dilated Cardiomyopathy Correlates with Rate of Fibrosis in Cardiac Tissue. 第69回日本不整脈心電学会学術大会. 札幌. 2023年7月6-9日.
馬場 理. Deciphering the pathophysiology of atherosclerotic plaques by using chemokine receptor specific PET imaging. 大学院教育コース (生活習慣病・老化・代謝医学コース). WEB. 2023年9月12日.
堀江貴裕. Med-Pharm Collaboration BLDG. 第3回研究交流サロン」／The 3rd Research Networking Salon 「Inhibition of miR-33b in humanized mice ameliorates nonalcoholic steatohepatitis. 京都. 2023年9月28日.
大林祐樹1、渡邉真1、渡部宏俊1、塩見紘樹1、竹治泰明1、布木誠之1、長田裕明2、友塚真栄2 、山﨑和裕2 、湊谷謙司2 、尾野亘1. MitraClip Symposium Controversial and Difficult-to-Treat Cases in Severe MR: A Case-Based Discussion, Severe degenerative non-central MR, Case presentation. 第1回K-SHD研究会. 大阪. 2023年12月9日.
Inazumi H, Ito M, Kasahara Y, Nakagawa Y. Development of a novel antiarrhythmic therapy using antisense oligonucleotide to improve the prognosis of cardiomyopathy. 第7回日本循環器学会基礎研究フォーラム. 神戸. 2023年12月9-10日.
Hai Huang. Histological characteristics of a rat model of LMNA-related cardiomyopathy carrying an Lmna missense variant, p.S143P. 第7回日本循環器学会基礎研究フォーラム. 神戸. 2023年12月9-10日.
堀江貴裕. Elucidation of metabolic regulatory mechanisms mediated by non-coding RNA and application to diseases. 令和5年度「生活習慣病・老化・代謝医学」大学院教育コースミーティング. WEB（京都）. 2023年12月12日.